Judge Dismisses Ixchel's Antitrust Claims Against Biogen
A California federal judge on Tuesday dismissed Ixchel Pharma LLC's claims alleging Biogen Inc. made an anti-competitive agreement to undermine Ixchel's development of a treatment for a rare neuromuscular disease, saying...To view the full article, register now.
Already a subscriber? Click here to view full article